CELC
Celcuity Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +23.1% ·
share flow +21.3% ·
net new positions +18.8%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 1.49M | $118.65M | n/a | −1 |
| Q2 2026 | 98 | +5 | 24.26M | $2.54B | +12 | −7 |
| Q1 2026 | 96 | +13 | 18.05M | $2.05B | +17 | −5 |
| Q4 2025 | 83 | -2 | 17.89M | $1.79B | +1 | −2 |
| Q3 2025 | 16 | +3 | 9.73M | $480.43M | +3 | n/a |
| Q2 2025 | 10 | 0 | 5.98M | $79.79M | +1 | −1 |
| Q1 2025 | 7 | 0 | 2.39M | $24.13M | n/a | n/a |
| Q4 2024 | 7 | -1 | 2.58M | $33.71M | +1 | −2 |
| Q3 2024 | 7 | -1 | 1.77M | $26.33M | +1 | −2 |
| Q2 2024 | 8 | n/a | 1.21M | $19.80M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 2.25M | +8.5% | $110.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | The Vanguard Group ✦ (passive) | 2.06M | +23.5% | $101.72M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 3 | Morgan Stanley ✦ | 1.51M | n/a | $74.73M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | Geode Capital Management ✦ (passive) | 766.47K | +13.2% | $37.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 722.80K | +23.1% | $35.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 598.16K | +3838.9% | $29.55M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 526.62K | +491.4% | $26.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Goldman Sachs Group ✦ | 422.94K | n/a | $20.89M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 371.94K | New | $18.37M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 194.80K | +1387.0% | $9.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 111.28K | +12.0% | $5.50M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 12 | JPMorgan Chase ✦ | 104.09K | n/a | $5.14M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 13 | Two Sigma Investments ✦ | 62.78K | New | $3.10M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 15.02K | -98.0% | $742,086 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 6.87K | New | $339,329 | 0.0% | New | 1 | SEC ↗ ×4 |
| 16 | Fidelity (FMR) ✦ | 3.01K | +10.7% | $148,565 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $18.37M | 0.0% |
| Two Sigma Investments | $3.10M | 0.0% |
| AQR Capital Management | $339,329 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 275 holders, 48.99M shares, $5.37B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
10.0% of class · View original SEC filing ↗